Abstract
Chronic low back pain (CLBP) conditions are highly prevalent and constitute the leading cause of disability worldwide. The Analgesic, Anesthetic, and Addiction Clinical Trial Translations Innovations Opportunities and Networks (ACTTION) public-private partnership with the US Food and Drug Administration and the American Pain Society (APS), have combined to create the ACTTION-APS Pain Taxonomy (AAPT). The AAPT initiative convened a working group to develop diagnostic criteria for CLBP. The working group identified 3 distinct low back pain conditions which result in a vast public health burden across the lifespan. This article focuses on: 1) the axial predominant syndrome of chronic musculoskeletal low back pain, 2) the lateralized, distally-radiating syndrome of chronic lumbosacral radicular pain 3) and neurogenic claudication associated with lumbar spinal stenosis. This classification of CLBP is organized according to the AAPT multidimensional framework, specifically 1) core diagnostic criteria; 2) common features; 3) common medical and psychiatric comorbidities; 4) neurobiological, psychosocial, and functional consequences; and 5) putative neurobiological and psychosocial mechanisms, risk factors, and protective factors. Perspective: An evidence-based classification of CLBP conditions was constructed for the AAPT initiative. This multidimensional diagnostic framework includes: 1) core diagnostic criteria; 2) common features; 3) medical and psychiatric comorbidities; 4) neurobiological, psychosocial, and functional consequences; and 5) putative neurobiological and psychosocial mechanisms, risk factors, and protective factors.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1138-1148 |
| Number of pages | 11 |
| Journal | Journal of Pain |
| Volume | 21 |
| Issue number | 11-12 |
| DOIs | |
| State | Published - Nov 1 2020 |
Funding
We thank Maria E. Frazer, BS, CCRC, for her manuscript production support. Disclosures: The views expressed in this article are those of the authors, none of whom has financial conflicts of interest relevant to the issues discussed in this manuscript. No official endorsement by the US Food and Drug Administration (FDA) should be inferred. Support was provided by the Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) public-private partnership with the FDA, which has received contracts, grants, and other revenue for its activities from the FDA, multiple pharmaceutical and device companies, and other sources. A complete list of current ACTTION sponsors is available at: http://www.acttion.org/partners.
| Funders |
|---|
| U.S. Food and Drug Administration |
| Food and Drug Administration |
Keywords
- Chronic low back pain
- diagnostic criteria
- lumbar spinal stenosis
- neurogenic claudication
- radicular back pain
- sciatica
ASJC Scopus subject areas
- Neurology
- Clinical Neurology
- Anesthesiology and Pain Medicine
Fingerprint
Dive into the research topics of 'AAPT Diagnostic Criteria for Chronic Low Back Pain'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS